Clinical Trial Update: X-Change HF - Exchange of the Existing Pacemaker/ICD in Bradycardia Patients Suffering From Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating exchange of the existing pacemaker/implantable cardioverter-defibrillator in bradycardia patients with heart failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Pacemaker/ICD

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Heart Failure, Congestive | Phase 4 | Status: TERMINATED